Pakistan vs Tunisia: Access to anti-retroviral drugs, female
Pakistan
24.0%
in 2024
Tunisia
33.0%
in 2024
Pakistan rank
136th
Tunisia rank
133rd
Access to anti-retroviral drugs, female over time
- Pakistan
- Tunisia
How they compare
Tunisia currently reports 33.0% against 24.0% in Pakistan, a difference of 9.0%.
That makes Tunisia's figure about 1.4 times Pakistan's.
Across all 25 years both countries report, Tunisia has been ahead every year.
Pakistan ranks 136th and Tunisia ranks 133rd of 141 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Pakistan | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.4% | 4.4% | 2.0% | Tunisia |
| 2010s | 6.9% | 19.9% | 13.0% | Tunisia |
| 2020s | 17.8% | 33.8% | 16.0% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Pakistan or Tunisia?
- Tunisia, at 33.0% against 24.0% in Pakistan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Pakistan and Tunisia?
- 9.0%, with Tunisia ahead.
- How many years of comparable data are there for Pakistan and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Pakistan and Tunisia rank globally for access to anti-retroviral drugs, female?
- Pakistan ranks 136th and Tunisia ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.